HIV Drug Resistance — An Emerging Threat to Epidemic Control von Beyrer, Chris, Pozniak, Anton

Volltext

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications von Marzolini, Catia, Kuritzkes, Daniel R., Marra, Fiona, Boyle, Alison, Gibbons, Sara, Flexner, Charles, Pozniak, Anton, Boffito, Marta, Waters, Laura, Burger, David, Back, David J., Khoo, Saye

Volltext

Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV von Lazarus, Jeffrey V., Safreed-Harmon, Kelly, Kamarulzaman, Adeeba, Anderson, Jane, Leite, Ricardo Baptista, Behrens, Georg, Bekker, Linda-Gail, Bhagani, Sanjay, Brown, Darren, Brown, Graham, Buchbinder, Susan, Caceres, Carlos, Cahn, Pedro E., Carrieri, Patrizia, Caswell, Georgina, Cooke, Graham S., Monforte, Antonella d’Arminio, Dedes, Nikos, del Amo, Julia, Elliott, Richard, El-Sadr, Wafaa M., Fuster-Ruiz de Apodaca, María José, Guaraldi, Giovanni, Hallett, Tim, Harding, Richard, Hellard, Margaret, Jaffar, Shabbar, Kall, Meaghan, Klein, Marina, Lewin, Sharon R., Mayer, Ken, Pérez-Molina, Jose A., Moraa, Doreen, Naniche, Denise, Nash, Denis, Noori, Teymur, Pozniak, Anton, Rajasuriar, Reena, Reiss, Peter, Rizk, Nesrine, Rockstroh, Jürgen, Romero, Diana, Sabin, Caroline, Serwadda, David, Waters, Laura

Volltext

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING... von Cahn, Pedro, Dr, Pozniak, Anton L, MD, Mingrone, Horacio, MD, Shuldyakov, Andrey, MD, Brites, Carlos, MD, Andrade-Villanueva, Jaime F, MD, Richmond, Gary, MD, Buendia, Carlos Beltran, MD, Fourie, Jan, MD, Ramgopal, Moti, MD, Hagins, Debbie, MD, Felizarta, Franco, MD, Madruga, Jose, MD, Reuter, Tania, MD, Newman, Tamara, MD, Small, Catherine B, MD, Lombaard, John, MD, Grinsztejn, Beatriz, MD, Dorey, David, MMath, Underwood, Mark, PhD, Griffith, Sandy, PharmD, Min, Sherene, MD

Volltext

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? von Hill, Andrew, Hughes, Sophie L, Gotham, Dzintars, Pozniak, Anton L

Volltext

Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials von Pilkington, Victoria, Hughes, Sophie L., Pepperrell, Toby, McCann, Kaitlyn, Gotham, Dzintars, Pozniak, Anton L., Hill, Andrew

Volltext

Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance von Wood, Brian R., Pozniak, Anton L.

Volltext

Are new antiretroviral treatments increasing the risks of clinical obesity? von Hill, Andrew, Waters, Laura, Pozniak, Anton

Volltext

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission von Bekker, Linda-Gail, Alleyne, George, Baral, Stefan, Cepeda, Javier, Daskalakis, Demetre, Dowdy, David, Dybul, Mark, Eholie, Serge, Esom, Kene, Garnett, Geoff, Grimsrud, Anna, Hakim, James, Havlir, Diane, Isbell, Michael T, Johnson, Leigh, Kamarulzaman, Adeeba, Kasaie, Parastu, Kazatchkine, Michel, Kilonzo, Nduku, Klag, Michael, Klein, Marina, Lewin, Sharon R, Luo, Chewe, Makofane, Keletso, Martin, Natasha K, Mayer, Kenneth, Millett, Gregorio, Ntusi, Ntobeko, Pace, Loyce, Pike, Carey, Piot, Peter, Pozniak, Anton, Quinn, Thomas C, Rockstroh, Jurgen, Ratevosian, Jirair, Ryan, Owen, Sippel, Serra, Spire, Bruno, Soucat, Agnes, Starrs, Ann, Strathdee, Steffanie A, Thomson, Nicholas, Vella, Stefano, Schechter, Mauro, Vickerman, Peter, Weir, Brian, Beyrer, Chris

Volltext

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials von Gupta, Samir K, Post, Frank A, Arribas, José R, Eron, Joseph J, Wohl, David A, Clarke, Amanda E, Sax, Paul E, Stellbrink, Hans-Jürgen, Esser, Stefan, Pozniak, Anton L, Podzamczer, Daniel, Waters, Laura, Orkin, Chloe, Rockstroh, Jürgen K, Mudrikova, Tatiana, Negredo, Eugenia, Elion, Richard A, Guo, Susan, Zhong, Lijie, Carter, Christoph, Martin, Hal, Brainard, Diana, SenGupta, Devi, Das, Moupali

Volltext

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV von Gallant, Joel E, DeJesus, Edwin, Arribas, José R, Pozniak, Anton L, Gazzard, Brian, Campo, Rafael E, Lu, Biao, McColl, Damian, Chuck, Steven, Enejosa, Jeffrey, Toole, John J, Cheng, Andrew K

Volltext

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised,... von Sax, Paul E, Dr Prof, Wohl, David, MD, Yin, Michael T, Prof, Post, Frank, MD, DeJesus, Edwin, MD, Saag, Michael, MD, Pozniak, Anton, MD, Thompson, Melanie, MD, Podzamczer, Daniel, MD, Molina, Jean Michel, Prof, Oka, Shinichi, MD, Koenig, Ellen, MD, Trottier, Benoit, MD, Andrade-Villanueva, Jaime, MD, Crofoot, Gordon, MD, Custodio, Joseph M, PharmD, Plummer, Andrew, MS, Zhong, Lijie, PhD, Cao, Huyen, MD, Martin, Hal, MD, Callebaut, Christian, PhD, Cheng, Andrew K, MD, Fordyce, Marshall W, MD, McCallister, Scott, MD

Volltext

Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy von van De Ven, Nikolien S, Pozniak, Anton L, Levi, Jacob A, Clayden, Polly, Garratt, Anna, Redd, Christopher, Mofenson, Lynne M, Hill, Andrew

Volltext

COVID-19 death in people with HIV: interpret cautiously von Waters, Laura J, Pozniak, Anton L

Volltext

Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk von Gatell, José M, Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans-Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Pozniak, Anton L

Volltext

High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya von Penner, Jeremy, Ombajo, Loice Achieng, Otieno, Davies, Nkuranga, Joseph, Mburu, Margaret, Wahome, Simon, Pozniak, Anton, Bhagani, Sanjay

Volltext

Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide von Cerrone, Maddalena, Alfarisi, Omamah, Neary, Megan, Marzinke, Mark A, Parsons, Teresa L, Owen, Andrew, Maartens, Gary, Pozniak, Anton, Flexner, Charles, Boffito, Marta

Volltext

How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP von Pilkington, Victoria, Hill, Andrew, Hughes, Sophie, Nwokolo, Nneka, Pozniak, Anton

Volltext

Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is fro... von WESTBY, Mike, LEWIS, Marilyn, WHITCOMB, Jeannette, YOULE, Mike, POZNIAK, Anton L, JAMES, Ian T, JENKINS, Tim M, PERROS, Manos, VAN DER RYST, Elna

Volltext

Episodic sexual transmission of HIV revealed by molecular phylodynamics von LEWIS, F, HUGHES, G.J, RAMBAUT, A, POZNIAK, A, BROWN, A.J.L

Volltext